PLRZ (Polyrizon) Moat Score: 1/10 (As of Jul. 02, 2026)


PLRZ Polyrizon Ltd PLRZ
14 GF Score
Price $12.60
! 4 Warning Signs
View Full Analysis

What is Polyrizon Moat Score?

Polyrizon PLRZ -0.08% 14 Moat Score is 1 as of Jul. 02, 2026. GuruFocus rates PLRZ with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 1,400 Biotechnology companies, Polyrizon ranks worse than 52.64% on this metric.

Polyrizon has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Polyrizon has No Moat: Polyrizon Ltd has no discernible moat, with minimal market presence and lack of significant competitive advantages. It does not possess strong brand strength, customer loyalty, or proprietary technology, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Polyrizon might have No Moat - Very weak/transient advantages.

Polyrizon  (NAS:PLRZ) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Polyrizon Moat Score Related Terms

PLRZ vs SKYE, NEUP, LGVN: Moat Score Comparison

For the Biotechnology subindustry, Polyrizon's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polyrizon Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polyrizon's Moat Score distribution charts can be found below:

* The bar in red indicates where Polyrizon's Moat Score falls into.


PLRZ
14GF Score
Polyrizon Ltd PLRZ
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Polyrizon (PLRZ) has a Moat Score of 1 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Polyrizon ranks #737 out of 1400 companies in the Biotechnology industry, placing it in the top 52.6%.
Is Polyrizon's Moat Score too high?
Polyrizon's current Moat Score is 1. The Biotechnology industry median Moat Score is 2.00. Polyrizon's value of 1 is 50% below this industry median. Based on the distribution chart, Polyrizon ranks #737 out of 1400 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Polyrizon has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Polyrizon's Moat Score compare to SKYE and NEUP?
According to the Biotechnology industry distribution chart, Polyrizon ranks #737 out of 1400 companies for Moat Score. This places Polyrizon in the lower half of its industry. The industry median Moat Score is 2.00. Polyrizon's value of 1 is 50% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,400 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polyrizon's current Moat Score of 1 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polyrizon's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polyrizon stock overvalued right now?
Polyrizon (PLRZ) has a current Moat Score of 1. The current Moat Score is 1 and 50% below the Biotechnology industry median of 2.00. Polyrizon's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Polyrizon (PLRZ), the current Moat Score is 1 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polyrizon Business Description

Address 5 Ha-Tidhar Street, Raanana, ISR, 4366507
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
14GF Score

Get the complete analysis for PLRZ

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.60
Price